89 related articles for article (PubMed ID: 17384650)
1. Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma.
Zhuang L; Lee CS; Scolyer RA; McCarthy SW; Zhang XD; Thompson JF; Hersey P
Mod Pathol; 2007 Apr; 20(4):416-26. PubMed ID: 17384650
[TBL] [Abstract][Full Text] [Related]
2. Fucoxanthin induces human melanoma cytotoxicity by thwarting the JAK2/STAT3/BCL-xL signaling axis.
Kuo MY; Dai WC; Chang JL; Chang JS; Lee TM; Chang CC
Environ Toxicol; 2024 Jun; 39(6):3356-3366. PubMed ID: 38444163
[TBL] [Abstract][Full Text] [Related]
3. Non-canonical role for the ataxia-telangiectasia-Rad3 pathway in STAT3 activation in human multiple myeloma cells.
Li L; Hu X; Nkwocha J; Sharma K; Kmieciak M; Mann H; Zhou L; Grant S
Cell Oncol (Dordr); 2023 Oct; 46(5):1369-1380. PubMed ID: 37126127
[TBL] [Abstract][Full Text] [Related]
4. Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma.
Su DG; Djureinovic D; Schoenfeld D; Marquez-Nostra B; Olino K; Jilaveanu L; Kluger H
JCO Precis Oncol; 2024 Apr; 8():e2300702. PubMed ID: 38662983
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor activating enhancer-binding protein 2ε (AP2ε) modulates phenotypic plasticity and progression of malignant melanoma.
Staebler S; Rottensteiner-Brandl U; El Ahmad Z; Kappelmann-Fenzl M; Arkudas A; Kengelbach-Weigand A; Bosserhoff AK; Schmidt SK
Cell Death Dis; 2024 May; 15(5):351. PubMed ID: 38773108
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 expression in metastatic malignant melanoma. Importance for the therapeutic efficacy of biochemotherapy.
Håkansson A; Gustafsson B; Abdiu A; Krysander L; Håkansson L
Cancer Immunol Immunother; 2003 Apr; 52(4):249-54. PubMed ID: 12669250
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking analysis of capsaicin with apoptotic proteins.
Roy A; Rasheed A; Sleeba AV; Rajagopal P
Bioinformation; 2020; 16(7):555-560. PubMed ID: 32994681
[TBL] [Abstract][Full Text] [Related]
8. STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different estrogen receptor-α immunoprofile.
Wincewicz A; Baltaziak M; Kanczuga-Koda L; Koda M; Sulkowska U; Famulski W; Sulkowski S
Gynecol Endocrinol; 2011 Aug; 27(8):536-40. PubMed ID: 21726118
[TBL] [Abstract][Full Text] [Related]
9. MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies.
Choudhary GS; Al-Harbi S; Mazumder S; Hill BT; Smith MR; Bodo J; Hsi ED; Almasan A
Cell Death Dis; 2015 Jan; 6(1):e1593. PubMed ID: 25590803
[TBL] [Abstract][Full Text] [Related]
10. Lipid raft: A floating island of death or survival.
George KS; Wu S
Toxicol Appl Pharmacol; 2012 Mar; 259(3):311-9. PubMed ID: 22289360
[TBL] [Abstract][Full Text] [Related]
11. Protection from endogenous perforin: glycans and the C terminus regulate exocytic trafficking in cytotoxic lymphocytes.
Brennan AJ; Chia J; Browne KA; Ciccone A; Ellis S; Lopez JA; Susanto O; Verschoor S; Yagita H; Whisstock JC; Trapani JA; Voskoboinik I
Immunity; 2011 Jun; 34(6):879-92. PubMed ID: 21658975
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules.
de Saint Basile G; Ménasché G; Fischer A
Nat Rev Immunol; 2010 Aug; 10(8):568-79. PubMed ID: 20634814
[TBL] [Abstract][Full Text] [Related]
13. Formation and function of the lytic NK-cell immunological synapse.
Orange JS
Nat Rev Immunol; 2008 Sep; 8(9):713-25. PubMed ID: 19172692
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery.
Hu Y; Dong Z; Liu K
J Exp Clin Cancer Res; 2024 Jan; 43(1):23. PubMed ID: 38245798
[TBL] [Abstract][Full Text] [Related]
15. Antimetastatic activity of seongsanamide B in γ-irradiated human lung cancer.
Ryoo GH; Kim GJ; Han AR; Jin CH; Lee H; Nam JW; Choi H; Jung CH
Heliyon; 2023 Sep; 9(9):e20179. PubMed ID: 37809399
[TBL] [Abstract][Full Text] [Related]
16. A Novel Nanoemulsion Formula for an Improved Delivery of a Thalidomide Analogue to Triple-Negative Breast Cancer; Synthesis, Formulation, Characterization and Molecular Studies.
Tawfik NM; Teiama MS; Iskandar SS; Osman A; Hammad SF
Int J Nanomedicine; 2023; 18():1219-1243. PubMed ID: 36937550
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and protein markers distinguishing the "polymerase epsilon exonuclease" from the "copy number low" subtype of endometrial cancer.
Kim K; Hwangbo S; Kim H; Kim YB; No JH; Suh DH; Park T
J Gynecol Oncol; 2022 May; 33(3):e27. PubMed ID: 35128857
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA CD27-AS1-208 Facilitates Melanoma Progression by Activating STAT3 Pathway.
Ma J; Shi Q; Guo S; Xu P; Yi X; Yang Y; Zhang W; Liu Y; Liu L; Yue Q; Zhao T; Gao T; Guo W; Li C
Front Oncol; 2021; 11():818178. PubMed ID: 35096622
[TBL] [Abstract][Full Text] [Related]
19. TFEB promotes BCL-2 expression by upregulating its promoter activity in the t(6;11) translocation renal cell carcinomas.
Zhan HQ; Qin R; Li YL; Liu MM; Gan L
Am J Transl Res; 2021; 13(8):8804-8818. PubMed ID: 34539996
[TBL] [Abstract][Full Text] [Related]
20. Degranulation enhances presynaptic membrane packing, which protects NK cells from perforin-mediated autolysis.
Li Y; Orange JS
PLoS Biol; 2021 Aug; 19(8):e3001328. PubMed ID: 34343168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
